News

Scinai Immunotherapeutics Ltd. , a biopharmaceutical company specializing in inflammation and immunology (I&I) biological products and providing CDMO services through its Scinai Bioservices unit, ...
Kerassentials is a meticulously formulated toenail infection treatment solution that targets more problematic issues, such as ...
ImmunoPrecise Antibodies Ltd. (IPA) a leader in AI-driven biotherapeutics, announces discovery of a highly conserved epitope across all four dengue virus serotypes using its proprietary LENSaitm ...
A pop-up overdose prevention tent is now running once a week in downtown St. John's. Overdose Awareness and Response St.
SHELTON, CT / ACCESS Newswire / June 4, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company ...
The U.S. Patent and Trademark Office (USPTO) held a “USPTO Hour” Wednesday in which it announced the results of a study it ...
The government’s Strong Borders Act would let Canada Post and police open mail, create powers to cancel immigration en masse and more ...
As a result of the decision, Shilpa will not be eligible to receive FDA approval for its lenvatinib mesylate generic until February 2036.
Five early-career Fred Hutch/UW researchers received prestigious Young Investigator Awards from Conquer Cancer, the ASCO Foundation during this year's annual meeting of the American Society of ...